Vorasidenib and grading of IDH mutant astrocytoma
Neuro-Oncology: The Podcast · Dr. Ankush Bhatia, Dr. Matthias Preusser, DR. Iyad Alnahhas
October 27, 202324m 11s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.